Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.

Blood - 1 Sept 2007

Schulze Zur Wiesch Julian, Lauer Georg M, Timm Joerg, Kuntzen Thomas, Neukamm Martin, Berical Andrew, Jones Andrea M, Nolan Brian E, Longworth Steve A, Kasprowicz Victoria, McMahon Cory, Wurcel Alysse, Lohse Ansgar W, Lewis-Ximenez Lia L, Chung Raymond T, Kim Arthur Y, Allen Todd M, Walker Bruce D

Abstract excerpt

Chronic hepatitis C virus (HCV) infection is typically characterized by a lack of virus-specific CD4(+) T-cell-proliferative responses, but strong responses have been described in a subset of persons with persistent viremia. One possible explanation for these responses is that they were primed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitope Mapping

Share to Epitopes, T-Lymphocyte

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Peptides

Share to Serotyping

Source

Open in PubMed Open full text

Identifiers

PMID: 17475911
DOI: 10.1182/blood-2007-01-069583
PMCID: PMC1975840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17475911-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.PMID 17475911Read ↗

Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection.Semantic proximity Read ↗

Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Semantic proximity Read ↗

Heterologous T cell immunity in severe hepatitis C virus infectionSemantic proximity Read ↗

Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.Semantic proximity Read ↗

Hepatitis C cross-genotype immunity and implications for vaccine development.Semantic proximity Read ↗

Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.Semantic proximity Read ↗

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.Semantic proximity Read ↗

HCV genotype-3a T cell immunity: specificity, function and impact of therapy.Semantic proximity Read ↗

Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.Semantic proximity Read ↗

Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.Semantic proximity Read ↗

High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.